Parexel to tap additional pharmacovigilance services with QSI acquisition

By Zachary Brennan

- Last updated on GMT

Parexel to tap additional pharmacovigilance services with QSI acquisition

Related tags Clinical research services Pharmacology

Global CRO Parexel has signed a definitive agreement to acquire privately-owned, Chandigarh, India-based Quantum Solutions India, a provider of specialized pharmacovigilance services. 

The acquisition is expected to close in early April, subject to the satisfaction of closing conditions. Financial details were not revealed though Parexel said the purchase will be funded with existing cash.  The impact of the acquisition on Parexel's FY 2015 revenue and earnings per share is not expected to be material. 

Established in 2004, QSI offers a range of pharmacovigilance services including individual case safety report processing, brand physician activities, affiliate support, aggregate report writing, literature reviews, and signal detection.  The company serves pharma, medical device and consumer clients and has approximately 900 employees.

A Parexel spokeswoman did not respond to a request for comment on whether Parexel would absorb all 900 of QSI’s employees though “additional details​” will be shared when the acquisition closes.

Josef von Rickenbach, Chairman and CEO of Parexel, said, "Combined with the existing post-approval and regulatory strengths of Parexel, this acquisition will support the expansion of our pharmacovigilance services onto a broader platform.  We are excited to be able to offer our clients QSI's leading services through our Clinical Research Services business​."

The QSI business will be integrated into Parexel's Peri/Post-Approval Services group which is part of the CRS (Clinical Research Services) segment.  It is also expected to synergies with the company’s Regulatory Outsourcing Services business.

The acquisition comes as Parexel recently expanded its site network​ to speed drug delivery, as well as acquired UK-based RTSM (Randomization and Trial Supply Management) company ClinIntel​.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us


View more